Disulfidptosis and its molecular mechanisms in cancer: mechanisms, regulation, and therapeutic potential
- 3 July 2026
- journal article
- review article
- Published by Springer Nature in Medical Oncology
- Vol. 43 (8) , 210
Abstract
Disulfidptosis is a novel form of programmed cell death. It is triggered by metabolic and redox imbalance. It is executed through the irreversible collapse of the actin cytoskeleton. Its core mechanism involves the ‘SLC7A11-cystine-NADPH-actin axis’. This process selectively kills cancer cells while sparing normal cells. This provides a new direction for low-toxicity anticancer therapy. This review systematically summarizes the multi-layered molecular regulatory network governing disulfidptosis. It elucidates the underlying mechanisms through several lenses. These include metabolic reprogramming (glucose metabolism, pentose phosphate pathway, cystine uptake), redox homeostasis (reactive oxygen species (ROS), glutathione system, thioredoxin system), cytoskeletal dynamics, and key signaling pathways such as Keap1-Nrf2, AMPK, and p53. The review clarifies its dual role in tumors. Cancer cells exhibit specific susceptibility due to metabolic reprogramming. Cells resistant to apoptosis or ferroptosis show heightened vulnerability. This stems from a ‘fragile redox equilibrium’. However, functional polarity reversal of core regulatory molecules and tumor heterogeneity can also impact therapeutic efficacy. Targeting key molecules in disulfidptosis or combining metabolic interventions shows promising anticancer potential. However, current research still faces bottlenecks. These include unclear heterogeneity mechanisms and a lack of highly specific tools. Future efforts should establish precise classification systems, develop targeted drugs, and explore synergistic strategies combining immunotherapy to promote clinical translation. Graphic abstractKeywords
Funding Information
- National Natural Science Foundation of China (82174232)
This publication has 266 references indexed in Scilit:
- Disulfidptosis and Enzymatic‐Therapy Augmented Cuproptosis via Adding Spear and Discarding Shield StrategySmall, 2025
- Gaudichaudione H Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Disulfidptosis via Regulating NRF2‐SLC7A11 Signaling PathwayAdvanced Science, 2025
- Nicorandil Ameliorates Depression‐Like Behaviors After Traumatic Brain Injury by Suppressing Ferroptosis Through the SLC7A11/GPX4 Axis in the HippocampusBrain and Behavior, 2024
- Disrupting Intracellular Homeostasis by Copper‐Based Nanoinducer with Multiple Enzyme‐Mimicking Activities to Induce Disulfidptosis‐Enhanced Pyroptosis for Tumor ImmunotherapyAdvanced Materials, 2024
- Inducing disulfidptosis in tumors:potential pathways and significanceMedcomm, 2024
- Nrf2 as a regulator of energy metabolism and mitochondrial functionFEBS Letters, 2024
- Design, Synthesis and Preliminary Bioactivity Evaluation of N‐Acetylcysteine Derivatives as Antioxidative and Anti‐Inflammatory AgentsChemMedChem, 2024
- Nrf2 in cancers: A double‐edged swordCancer Medicine, 2019
- Disulfide bond based polymeric drug carriers for cancer chemotherapy and relevant redox environments in mammalsMedicinal Research Reviews, 2018
- From structure to redox: The diverse functional roles of disulfides and implications in diseaseProteomics, 2017